LY450139

semagacestat · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LY450139, covering 2008-10-02 to 2014-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo [Phase 3]